HTB homepage • Conference reports • Articles by subject • Subscribe September 2000 Contents Treatment alerts Abacavir hypersensitivity cases following an interruption of therapy Antiretrovirals Videx EC (ddI, didanosine) – food restrictions Importance of protease inhibitor plasma levels in patients treated with genotypic-guided therapy Flavopiridol inhibits cellular processes essential to replication of HIV Abbott expands early-access program for ABT-378/r (Kaletra) Roche and Trimeris announce intention to manufacture commercial supplies of anti-HIV fusion inhibitor T-20 PRO-542 shows efficacy in trial Treatment strategies Structured treatment interruptions and treatment intensification Treatment access Loans to buy AIDS drugs are rejected by Africans Paediatric care Adverse effects of perinatal zidovudine exposure on HIV-infected infants Early cognitive and motor developmental delays in HIV-infected infants Topical cidofovir clears severe molluscum contagiosum in children with AIDS Side effects HAART: enough to make your hair curl? Coinfections and complications Prevalence of psoriatic arthritis increasing among HIV-positive black Zambians Basic science and immunology Duration of incubation affects subsequent rate of HIV disease progression Population of HIV-targeted CD8 cells fluctuates with viral load during chronic infection Vaccines and microbicides Murabutide inhibits HIV replication in macrophages and dendritic cells Other news Scrub typhus: infection reduces viral load in some patients Immunorestitution disease PDFs Volume 1 Number 6 September 2000 PDF HTB homepage • Conference reports • Articles by subject • Subscribe